The largest database of trusted experimental protocols

Fgm 2 fibroblast growth medium 2 bulletkit

Manufactured by Lonza
Sourced in Switzerland

The FGM-2 Fibroblast Growth Medium-2 BulletKit is a cell culture medium designed for the growth and maintenance of human fibroblast cells. It provides the necessary nutrients and growth factors required for the proliferation and survival of fibroblasts in vitro.

Automatically generated - may contain errors

9 protocols using fgm 2 fibroblast growth medium 2 bulletkit

1

Cell Culture Protocols for Stem Cell Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human dermal fibroblast cells, STO cells, and PLAT-GP packaging cells were purchased commercially (ATCC, Manassas, VA, USA). The fibroblast growth medium-2 (FGM-2) Bulletkit (Lonza, Tewkesbury, UK) was used for human dermal fibroblast cultures, whereas Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Waltham, MA, USA) containing Glutamax (2 mM; Gibco), penicillin/streptomycin (100 U/mL; Gibco), and fetal bovine serum (FBS, 10%; Life Technologies, Carlsbad, CA, USA) were used for STO and PLAT-GP packaging cells. DMEM/Ham’s F-12 (DMEM/F12; Gibco) medium for human iPSCs and human ES cells contained knockout serum replacement (SR, 20%; Gibco), Glutamax (2 mM; Gibco), nonessential amino acids (NEAA, 0.1 mM; Gibco), 2-mercaptoethanol (0.1 mM; Gibco), 50 U penicillin/streptomycin, and basic fibroblast growth factor (bFGF, 10 μg/mL; Bio-tech/R&D Systems, Minneapolis, MN, USA).
+ Open protocol
+ Expand
2

Culturing Human Breast Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cell lines (BCCLs), SkBr3, MDA-MB-468, T47D, purchased from the American Type Culture Collection, were cultured in McCoy’s 5A (SkBr3) or Dulbecco’s modified Eagle’s medium (MDA-MB-468, T47D) (Lonza, Slough, UK) supplemented with 5% (T47D) or 10% fetal bovine serum (Lonza). The human normal fibroblast (NF) cell line NHDF (normal human dermal fibroblasts), derived from human normal derma (Lonza) was cultured in Fibroblast Basal Medium (FBM) supplemented with Fibroblast Growth Medium-2 (FGM-2) Bullet kit (Lonza), containing 2% fetal bovine serum (FBS), 0.1% Insulin, 0.1% gentamicin, amphotericin GA 1000, 0.1% fibroblast growth factor (FGF). All cell lines were cultured at 37 °C in 95% humidified air in the presence of 5% CO2 and authenticated with short tandem repeat DNA profiling analysis by the Functional Genomic Unit of the Department of Experimental Oncology at Fondazione IRCCS Istituto Nazionale Tumori of Milano (INT).
+ Open protocol
+ Expand
3

Evaluating Farnesol's Impact on Fibroblast Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
CellTiter 96® AQueous One Solution Cell Proliferation (MTS) assay (Promega) was used to determine the viability of human dermal fibroblasts from adult (HDFa) (Lonza) when exposed to farnesol. Cells (5000/cm2) were cultured with 200 μl of FGM™-2 fibroblast growth medium-2 BulletKit™ (Lonza) in a collagen-coated 96-well plate to form a monolayer (≥80 % of confluence) in a 37 °C, 5 % CO2, humidified incubator. The medium was aspirated, cells were washed with 200 μl of PBS, and then incubated with 200 μl of medium containing 1, 6, or 15 mg/ml of farnesol. Cells were exposed to medium only, or medium containing the same amount of ethanol but without farnesol as medium and vehicle controls. After 24-hr incubation, the medium was aspirated, and the attached cells were washed with 200 μl of PBS, followed by the addition of 100 μl of MTS solution which had been diluted 1:4 with medium. The plate was incubated in the 37 °C, 5 % CO2, humidified incubator for 2–4 h, while protected from light. The optical density at 490 nm was then measured using a TECAN Infinite M200 microplate reader with the MTS solution alone as a blank.
+ Open protocol
+ Expand
4

Synovial Sarcoma Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synovial sarcoma cell lines Hssy-II, Syo-I, Yamato, and Aska were maintained in Eagle's minimum essential medium supplemented with 10% fetal bovine serum. Human skeletal muscle cell (SKMC) (CC-2561) was purchased from Lonza (Lonza Walkersville, Inc., Walkersville, MD) and maintained with SkGM Skeletal Muscle Cell Growth Medium BulletKit (CC-3160). Human dermal fibroblast (HFB) (CC-2511) was purchased from Lonza (Lonza Walkersville, Inc.) and maintained with FGM-2 Fibroblast Growth Medium-2 BulletKit (CC-3132). Protocols from the manufacturer were followed during the culture process. All cells were maintained at 37°C in a humidified atmosphere containing 5% CO2. Pure FKA (F4502) was obtained from LKT Laboratories, C1 compound (HY-16661) was obtained from MedChemExpress, and Z-VAD-FMK (FMK001) was obtained from R&D Systems. These reagents were dissolved in dimethyl sulfoxide (DMSO) and stored at −20°C.
+ Open protocol
+ Expand
5

Cell Elasticity Mapping by AFM Force Spectroscopy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Force spectroscopy measurements and elasticity maps from cells were collected by using a commercially available atomic force microscope (model XE-120, Park System). The PDMS samples covered with a monolayer of cells were placed inside the Petri dish lid and filled with cell culture medium (FGM–2 Fibroblast Growth Medium-2 BulletKit, Lonza, catalog number: CC-3132). Samples prepared in this way were mounted on the AFM. The ORC8-10 D AFM probe was used, a commercially available silicon nitride from Bruker. The tip was immersed in medium and approached close to the cell’s surface. Force curves (i.e., vertical deflection vs. scanner position) were collected within a grid of 5 × 5 points from approximately 40 different cells, for each substrate and time point. To estimate the quantity of the relative Young’s modulus, only the approach section of the collected force curve was analyzed. It was recalculated into a force versus indentation curve. After that, the Hertz contact model was fitted, with a paraboloid approximation of the shape of the probing tip [97 (link)].
+ Open protocol
+ Expand
6

Fibroblast Growth Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were obtained: FGM-2 Fibroblast Growth Medium-2 Bullet Kit (Lonza, Basel, Switzerland); 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich, St Louis, MO, USA); PBS (Lonza, Basel, Switzerland); dimethyl sulfoxide (Sigma-Aldrich, St Louis, MO, USA); trypan blue (Invitrogen, Carlsbad, CA, USA); TRIzol reagent (Invitrogen, Carlsbad, CA, USA); SensiFAST SYBR No-ROX One-Step (Bioline, London, UK); and oligonucleotide specific primers (Sigma-Aldrich, St Louis, MO, USA).
+ Open protocol
+ Expand
7

Cellular Elasticity Mapping by AFM

Check if the same lab product or an alternative is used in the 5 most similar protocols
Force spectroscopy measurements and the collection of elasticity maps from cells were carried using an atomic force microscope (AFM, model XE-120, Park System, Suwon, Korea) with commercially available silicon nitride AFM probes (ORC8-10 D, Bruker, Bremen, Germany). The samples covered with a monolayer of cells were placed inside a Petri dish lid, filled with cell culture medium (FGM–2 Fibroblast Growth Medium-2 BulletKit, Lonza, Basel, Switzerland, catalog number: CC-3132), and mounted on the AFM. The tip then approached close to the cell surface and force curves were collected within a grid of 5 × 5 points from about 40 different cells, for each substrate and time point. To estimate the quantity of the relative Young’s modulus, only an approach part of the collected force curve was analyzed using the Hertz contact model, with a paraboloid approximation of the probing tip shape [101 (link)].
+ Open protocol
+ Expand
8

Hypoxia Effects on Lung Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human alveolar epithelial cell line A549 and diseased human lung fibroblasts from patients with idiopathic pulmonary fibrosis (DHLF-IPF cells) were obtained from the Korean Cell Line Bank (Seoul, South Korea) and Lonza (Basel, Switzerland), respectively. A549 cells were cultured in RPMI-1640 medium (Gibco Cell Culture, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin–streptomycin (Gibco), and DHLF-IPF cells were grown using an FGM-2 Fibroblast Growth Medium-2 BulletKit (Lonza). For hypoxic incubation, cells were incubated in a hypoxic incubator (New Brunswick Scientific, Edison, NJ, USA) with a humidified environment consisting of 1% O2, 5% CO2, and 94% N2.
+ Open protocol
+ Expand
9

Derivation of chiPSC1.5 iPSC Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
A chiPSC1.5 iPSC cell line was derived from normal female adult human dermal fibroblast (Lonza CC-2511). Briefly, an early passage (P2) was plated at 3500-cells/cm2 in FGM-2 fibroblast growth medium-2 BulletKit (Lonza, CC-3132). Reprograming of human fibroblasts was achieved by using ReproRNA-OKSGM a single-stranded RNA replicon vector that contains the five reprograming factors: OCT4, KLF-4, SOX2, GLIS1 and c-MYC (Stem Cell Technologies (STC) 05930). The manufacturer’s protocol was followed for reprograming the human fibroblasts. Peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood a female patient (Støy et al., 2008) carrying the KCNJ11 mutation V59M. PBMCs were reprogramed by the Cincinnati Children’s Hospital Pluripotent stem cell facility. Following adaptation to mTeSR1 and matrigel conditions, cell lines were cryopreserved and tested for mycoplasma (PromoKine PK-CA20-700–20). Standard metaphase spreads and G-banded karyotypes were determined by Wi-Cell Laboratories (Madison, WI).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!